Skip to content

TETRALOGIC PHARMACEUTICALS Corp

Delisted

CIK 1361248fmd_1GZETBQSQFAK7P8JASB28YPSM7Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2016, 15 periods

Latest annual · FY2015

Millions
Total revenues
0
Operating income
(45)
Net income
(50)
Free cash flow
(35)

Latest quarter · Q3 FY2016

Millions
Total revenues
0
Operating income
(9)
Net income
(9)
Open Financials

TETRALOGIC PHARMACEUTICALS Corp financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Revenue$010-K 2016-03-16 · proof
Operating income-$45 million-$33.8 million10-K 2016-03-16 · proof
Net income-$49.7 million-$36 million10-K 2016-03-16 · proof
Cash from operating activities-$34.9 million-$32.4 million10-K 2016-03-16 · proof
Free cash flow-$35 million-$32.9 million10-K 2016-03-16 · proof
Total assets$64 million$116.6 million-45.1%10-K 2016-03-16 · proof
Total liabilities$70 million$83.2 million-15.9%10-K 2016-03-16 · proof
Cash and cash equivalents$15.3 million$13.1 million+17.1%10-K 2016-03-16 · proof
What was TETRALOGIC PHARMACEUTICALS Corp's revenue in fiscal 2015?
TETRALOGIC PHARMACEUTICALS Corp reported revenue of $0 for fiscal 2015 (the year ended Dec 31, 2015). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What was TETRALOGIC PHARMACEUTICALS Corp's operating income in fiscal 2015?
TETRALOGIC PHARMACEUTICALS Corp reported operating income of -$45 million for fiscal 2015 (the year ended Dec 31, 2015), against -$33.8 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What was TETRALOGIC PHARMACEUTICALS Corp's net income in fiscal 2015?
TETRALOGIC PHARMACEUTICALS Corp reported net income of -$49.7 million for fiscal 2015 (the year ended Dec 31, 2015), against -$36 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What was TETRALOGIC PHARMACEUTICALS Corp's cash from operating activities in fiscal 2015?
TETRALOGIC PHARMACEUTICALS Corp reported cash from operating activities of -$34.9 million for fiscal 2015 (the year ended Dec 31, 2015), against -$32.4 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What was TETRALOGIC PHARMACEUTICALS Corp's free cash flow in fiscal 2015?
TETRALOGIC PHARMACEUTICALS Corp reported free cash flow of -$35 million for fiscal 2015 (the year ended Dec 31, 2015), against -$32.9 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What are TETRALOGIC PHARMACEUTICALS Corp's total assets?
As of Dec 31, 2015, TETRALOGIC PHARMACEUTICALS Corp reported total assets of $64 million, against $116.6 million a year earlier (-45.1%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What are TETRALOGIC PHARMACEUTICALS Corp's total liabilities?
As of Dec 31, 2015, TETRALOGIC PHARMACEUTICALS Corp reported total liabilities of $70 million, against $83.2 million a year earlier (-15.9%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC
What are TETRALOGIC PHARMACEUTICALS Corp's cash and cash equivalents?
As of Dec 31, 2015, TETRALOGIC PHARMACEUTICALS Corp reported cash and cash equivalents of $15.3 million, against $13.1 million a year earlier (+17.1%). Source: the 10-K filed with the SEC on Mar 16, 2016. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1361248&period_type=annual&limit=5"

Information only, not investment advice.